Delta-Fly Pharma, Inc.
Status: Publicly traded
Direct answer
Delta-Fly Pharma, Inc. is publicly traded on JPX under the ticker 4598.T.
Delta-Fly Pharma, Inc., established in Tokushima, Japan, in 2010, is a biotechnology company focused on the development of innovative oncology drugs. Their comprehensive pipeline includes several drug candidates targeting various cancers. DFP-10917 is currently undergoing Phase III clinical evaluation in the United States and Phase I in Japan for relapsed/refractory acute myeloid leukemia. Another significant...
Can you invest in Delta-Fly Pharma, Inc.?
Yes. Delta-Fly Pharma, Inc. trades publicly on JPX as 4598.T.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Delta-Fly Pharma, Inc.
Detailed equity research is provided by MarketSnap.